Thanks to a new technology, the diagnosis of brain cancer undergoes a breakthrough. The credit goes to cancer diagnostics company and University of Strathclyde Dxcover spin-out company. The company has indeed launched the liquid biopsy Dxcover, which was also effective in the early days of cancer growth, at a smaller volume and earlier stage.
q
There Research was published in the scientific journal Cancers.
Brain cancer: here are the advantages of the Dxcover liquid biopsy
According to Cancer Research UK, a 12,000 people in Britain are diagnosed with brain cancer each year and survival rates are 12% five years after diagnosis.
Read Also
- Natterjack toad and sand lizard lose out to grandstands on circuit in Zandvoort, but will F1 continue? Aug 12, 2021
- Dominican Republic, increasingly aimed at recycling Jun 5, 2022
- Technology predictions that came true with great movie classics like Star Trek, Fahrenheit 451 and more Jun 5, 2022
- “Bailando Así”, the new single by Angelo Perrone May 11, 2022
- Ferrari and Lamborghini, no discounts on the electric | FormulaPassion.it Sep 6, 2021
- The new Apple Watch 6 has the ability to measure oxygen in blood Sep 18, 2020
- Manufacturers agree on the future European combat aircraft Nov 18, 2022